Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 02:00 save search
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
Published: 2024-04-12 (Crawled : 02:00) - prnewswire.com
AMPL | $9.82 -0.2% -0.2% 280K
|
|
| O: -0.44%
H: 0.0%
C: 0.0%
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: -8.65%
H: 4.14%
C: 1.18%
CKPT | $1.43 -1.38% -1.4% 350K
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
deadline
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
Published: 2024-03-20 (Crawled : 02:00) - globenewswire.com
AQST | $4.265 -2.63% -2.7% 1.7M
|
Health Technology
|
| O: -13.86%
H: 2.17%
C: -2.07%
million offering therapeutics
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
Published: 2024-03-12 (Crawled : 02:00) - prnewswire.com
CALT | $18.0825 -1.71% 1.9K
|
Health Technology
|
| O: 1.48%
H: 0.44%
C: -2.26%
nefecon fda drug grants therapeutics
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
Published: 2024-02-29 (Crawled : 02:00) - prnewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.51%
H: 0.17%
C: -0.52%
VKTX | $64.99 1.79% 1.75% 2M
|
Health Technology
|
| O: -4.5%
H: 3.38%
C: -14.63%
LGND | $69.97 2.1% 2.06% 140K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: -6.71%
million offering therapeutics
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
Published: 2024-02-20 (Crawled : 02:00) - alteritytherapeutics.com
ATHE | $2.14 0.47% 0.47% 32K
|
Health Technology
|
| O: -1.96%
H: 4.0%
C: 1.5%
meeting therapeutics
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units
Published: 2024-02-02 (Crawled : 02:00) - globenewswire.com
XRTX | News | $2.88 -2.41% 8.3K
|
Mining, Quarrying, and Oil and ...
|
| O: -1.28%
H: 0.0%
C: -3.46%
offering
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors - Technavio
Published: 2024-01-26 (Crawled : 02:00) - prnewswire.com
XLO | $1.06 -3.64% -3.77% 450K
|
Professional, Scientific, and T...
|
| O: 4.69%
H: 4.55%
C: -2.99%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 2.92%
H: 1.06%
C: -3.05%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 1.07%
H: 0.1%
C: -0.94%
AGEN A | $6.44 11.61% 10.4% 1.7M
|
Health Technology
|
| O: 3.13%
H: 11.02%
C: 7.11%
protein growth market
Top Labor and Employee Benefits Issues to Think About in M&A Deals – Gibson Dunn
Published: 2024-01-18 (Crawled : 02:00) - spacfeed.com
KGS | $27.72 0.62% 0.0% 310K
|
n/a
|
| O: 1.03%
H: 0.51%
C: 0.46%
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: -7.14%
H: 23.08%
C: 7.69%
employee benefits
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - CERE, WAVD, ICVX, EAR
Published: 2023-12-28 (Crawled : 02:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.75%
H: 0.24%
C: -0.32%
EAR | $2.57 7.78% 200K
|
Health Technology
|
| O: 0.78%
H: 0.78%
C: 0.39%
CERE | $41.99 -0.26% -0.26% 1.4M
|
Finance
|
| O: 0.52%
H: 0.82%
C: -0.19%
Global Branded PAH Therapeutics Market Report 2023-2029 - Targeted Therapies Revolutionize Treatment, Growing Prevalence Spurs Market Expansion for Branded Therapeutics
Published: 2023-12-15 (Crawled : 02:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
report expansion global growing therapeutics market
Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China's National Reimbursement Drug List
Published: 2023-12-14 (Crawled : 02:00) - prnewswire.com
KPTI | $1.085 -3.98% -4.15% 1.6M
|
Health Technology
|
| O: 3.07%
H: 9.75%
C: 5.02%
xpovio drug
Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data in Relapsed/Refractory Multiple Myeloma (RRMM) at ASH 2023 and Announces Selection of Recommended Phase 2 Dose (RP2D)
Published: 2023-12-12 (Crawled : 02:00) - globenewswire.com
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 7.11%
H: 3.61%
C: -7.11%
hpn217 therapeutics
Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)
Published: 2023-12-11 (Crawled : 02:00) - prnewswire.com
KPTI | $1.085 -3.98% -4.15% 1.6M
|
Health Technology
|
| O: -1.36%
H: 12.13%
C: -8.31%
durability study
Kymera Therapeutics Presents Interim Results from STAT3 Degrader Phase 1 Clinical Trial at American Society of Hematology Annual Meeting
Published: 2023-12-11 (Crawled : 02:00) - globenewswire.com
KYMR | $35.7 3.93% 3.78% 440K
|
Health Technology
|
| O: -0.91%
H: 0.66%
C: -4.39%
meeting trial therapeutics results
Moore Kuehn, PLLC Encourages UiPath, Inc. Investors to Contact Law Firm
Published: 2023-12-08 (Crawled : 02:00) - prnewswire.com
FMC A | $58.65 0.69% 0.0% 1.6M
|
Process Industries
|
| O: 1.05%
H: 1.1%
C: -0.13%
BTAI | News | $2.965 4.04% 3.88% 410K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -9.94%
moore
ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering
Published: 2023-12-07 (Crawled : 02:00) - globenewswire.com
ZVSA | $0.5605 -2.49% -2.55% 150K
|
|
| O: -42.06%
H: 42.74%
C: -7.26%
offering
GCT DEADLINE TOMORROW: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GigaCloud Technology Inc. Investors with Losses to Secure Counsel Before Important December 4 Deadline in Securities Class Action - GCT
Published: 2023-12-04 (Crawled : 02:00) - prnewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: -17.51%
H: 18.05%
C: 12.0%
AHCO | $9.79 1.98% 1.94% 970K
|
Finance
|
| O: 1.02%
H: 4.71%
C: 3.14%
deadline global technology
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLI
Published: 2023-11-28 (Crawled : 02:00) - prnewswire.com
EH | $17.315 1.85% 1.82% 840K
|
Technology Services
|
| O: -0.11%
H: 4.11%
C: 0.26%
BCLI A | $0.531 -1.69% -1.71% 170K
|
Health Technology
|
| O: 3.4%
H: 0.0%
C: -8.33%
deadline cell therapeutics
Advanced wound care market to grow by USD 4.02 million from 2022 to 2027|3M Co., 4L Health Co. Ltd., Anika Therapeutics Inc., Cardinal Health Inc., Carilex Medical Inc. and more among the key companies - Technavio
Published: 2023-11-09 (Crawled : 02:00) - prnewswire.com
MDT | $81.29 0.89% 0.0% 5.2M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.38%
ANIK | $25.765 -0.71% -0.72% 36K
|
Health Technology
|
| O: 0.0%
H: 1.01%
C: -1.69%
companies health care medical therapeutics market
Energy Drinks Market will grow at a CAGR of 7.56% between 2021 and 2026 | Demand for low-calorie energy drinks boosts market growth - Technavio
Published: 2023-11-09 (Crawled : 02:00) - prnewswire.com
FIZZ | $44.4 -0.63% -0.63% 150K
|
Consumer Non-Durables
|
| O: 0.0%
H: 0.57%
C: -1.23%
ANIK | $25.765 -0.71% -0.72% 36K
|
Health Technology
|
| O: 0.0%
H: 1.01%
C: -1.69%
energy growth market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.